Janet Garland
Nurse Practitioner · Idaho Falls, IDNPI 1417957176
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,337 of the $5,393 with a category attached, or 80.4%. 25 manufacturers reported payments, led by Medtronic at 25.9% of the total. 2025 is the largest year on record at $2,069, 4.0 times the $516 reported in 2021. Among nurse practitioner clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $24.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Actelion Pharmaceuticals US, Inc.$839
- Abbott$749
- Novartis$580
- Amgen$273
- E.r. Squibb & Sons, L.L.C.$196
- plus $1K from 19 others
What the payments were for
- Travel & lodging$96618%
- Food & beverage$4,33780%
- Education$912%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 15 | $1,400 |
| Actelion Pharmaceuticals US, Inc. | 30 | $839 |
| Abbott | 40 | $749 |
| Novartis | 52 | $580 |
| Amgen | 7 | $273 |
| E.r. Squibb & Sons, L.L.C. | 8 | $196 |
| Boston Scientific | 8 | $190 |
| Merck | 9 | $167 |
| Edwards Lifesciences | 4 | $165 |
| Johnson & Johnson | 12 | $153 |
| AbbVie | 2 | $141 |
| Pfizer | 6 | $110 |
| Cvrx, Inc. | 4 | $59 |
| Philips North America LLC | 3 | $55 |
| Boehringer Ingelheim | 1 | $50 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| Bristol Myers Squibb | 1 | $33 |
| Viatris Specialty LLC | 2 | $32 |
| Mylan Specialty L.p. | 2 | $31 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $30 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| AstraZeneca | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,393 in reported general payments places this provider in the 95th percentile of 570 nurse practitioner providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 101 | $85,029 |
| EntrestoSacubitril/Valsartan | 55 | $40,621 |
| MounjaroTirzepatide | 27 | $24,255 |
| XareltoRivaroxaban | 16 | $15,661 |
| FarxigaDapagliflozin Propanediol | 12 | $10,594 |
| Midodrine Hcl | 35 | $6,057 |
| Potassium Chloride | 194 | $4,257 |
| Isosorbide Dinitrate | 40 | $1,989 |
| Metoprolol Succinate | 111 | $1,933 |
| Torsemide | 84 | $1,923 |
| Gabapentin | 74 | $1,778 |
| SotalolSotalol Hcl | 81 | $1,724 |
| Nifedipine ErNifedipine | 39 | $1,703 |
| Levothyroxine Sodium | 123 | $1,518 |
| Atorvastatin Calcium | 124 | $1,487 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $110 | $85,029101 claims |
| NovartisEntresto | $580 | $40,62155 claims |
| Lilly USA, LLCMounjaro | $13 | $24,25527 claims |
| Johnson & JohnsonXarelto | $153 | $15,66116 claims |
| AstraZenecaFarxiga | $14 | $10,59412 claims |
| AbbVieSynthroid | $141 | $97011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 570 nurse practitioner providers in Idaho.
Other nurse practitioner in Idaho Falls
- Amanda ThompsonIdaho Falls$67K
- Christina FinnertyIdaho Falls$10K
- Deven WillardsonIdaho Falls$10K
- Stephanie LeonardsonIdaho Falls$7K
- Christy TaylorIdaho Falls$6K
- Rachel PetrusIdaho Falls$5K
- Victoria BlairIdaho Falls$5K
- Kylee JohnsonIdaho Falls$3K
- Brandee SimpsonIdaho Falls$3K
- Kathleen CliffordBoise$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.